ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,320,000 | +49.1% | 93,250 | -21.5% | 0.02% | +43.8% |
| Q1 2019 | $2,898,000 | +369.7% | 118,855 | +174.3% | 0.02% | +300.0% |
| Q4 2018 | $617,000 | -44.6% | 43,330 | -40.8% | 0.00% | -33.3% |
| Q3 2018 | $1,113,000 | -56.3% | 73,220 | -51.8% | 0.01% | -57.1% |
| Q2 2018 | $2,547,000 | +33.7% | 151,765 | +30.0% | 0.01% | +27.3% |
| Q1 2018 | $1,905,000 | +42.4% | 116,725 | +7.3% | 0.01% | +37.5% |
| Q3 2017 | $1,338,000 | +1116.4% | 108,815 | +729.7% | 0.01% | +700.0% |
| Q2 2017 | $110,000 | -93.7% | 13,115 | -94.9% | 0.00% | -93.3% |
| Q3 2016 | $1,748,000 | +88.6% | 258,935 | -0.6% | 0.02% | +87.5% |
| Q2 2016 | $927,000 | +15.0% | 260,460 | -4.7% | 0.01% | +14.3% |
| Q1 2016 | $806,000 | -32.0% | 273,320 | -2.7% | 0.01% | -36.4% |
| Q4 2015 | $1,185,000 | +1545.8% | 280,820 | +1684.1% | 0.01% | +1000.0% |
| Q3 2015 | $72,000 | – | 15,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |